Product Code: SR1323A217_Report
The global bio-implants market size reached US$ 117.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 189.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.12% during 2023-2028.
Bio-implants are prostheses that are used for replacing, supporting or enhancing a biological structure. They are made up of different biosynthetic materials like collagen and tissue-engineered products like artificial skin. Bio-implants are majorly divided into three categories: biological implants that constitute bioartificial organs, cell therapy and tissue engineering; biologized implants that comprise of in-vivo cell lining, technical implants and biohybrid systems; and biofunctionalized implants that include surface-functionalized implants and drug-eluting stents. Bio-implants have been planted in various spheres of ENT and have resulted in some of the most successful surgical outcomes. They help to regularize physiological functions of patients which allows them to lead an efficient life.
Global Bio-Implants Industry Drivers:
- The growth of the bio-implants market is driven by a rise in the geriatric population around the world which is the largest end-user of these implants. Moreover, technological advancements and increasing awareness about the success of cosmetic implantations are providing a positive thrust to the market growth. Further, as dental implants are one of the biggest contributors to the growth of the bio-implants market, an increase in dental issues across the globe is aiding the market growth. Additionally, cardiac pacemakers and orthopaedic artificial implants are in constant demand owing to the growing prevalence of cardiovascular and orthopaedic conditions.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global bio-implants market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type of bio-implants, material, origin, mode of administration and end-user.
Breakup by Type of Bio-Implants:
- Cardiovascular Implants
- Dental Implants
- Spinal Bio-implants
- Orthopaedic Implants
- Ophthalmic Implants
- Others
- Based on the type of bio-implants, the market has been segmented into cardiovascular implants, dental implants, spinal bio-implants, orthopaedic implants, ophthalmic implants and others.
Breakup by Material:
- Metallic
- Ceramic
- Polymer
- Biological
- Based on the type of material, the market has been segmented into metallic, ceramic, polymer and biological.
Breakup by Origin:
- Allograft
- Autograft
- Xenograft
- Synthetic
- Based on the origin, the market has been segmented into allograft, autograft, xenograft and synthetic.
Breakup by Mode of Administration:
- Non Surgical
- Surgical
- Based on the mode of administration, the market has been segmented into non-surgical and surgical.
Breakup by End-User:
- Ambulatory Surgical Centers
- Clinics
- Hospital
- Others
- Based on the end-user, the market has been segmented into ambulatory surgical centers, clinics, hospital and others.
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
- Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape:
- The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, St. Jude Medical Inc, Medtronic Inc., Smith and Nephew, Wright Medical Group, Zimmer Biomet, Dentsply Sirona, Invibio Limited, Straumann, Danaher Corporation, Cardinal Health, Johnson & Johnson, B. Braun Melsungen, LifeNet Health, Inc and Endo International plc.
Key Questions Answered in This Report:
- 1. What was the size of the global bio-implants market in 2022?
- 2. What is the expected growth rate of the global bio-implants market during 2023-2028?
- 3. What are the key factors driving the global bio-implants market?
- 4. What has been the impact of COVID-19 on the global bio-implants market?
- 5. What is the breakup of the global bio-implants market based on the type of bio-implants?
- 6. What is the breakup of the global bio-implants market based on the origin?
- 7. What is the breakup of the global bio-implants market based on the end-user?
- 8. What are the key regions in the global bio-implants market?
- 9. Who are the key players/companies in the global bio-implants market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Bio-Implants Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Breakup by Type of Bio-Implants
- 5.5 Market Breakup by Material
- 5.6 Market Breakup by Origin
- 5.7 Market Breakup by Mode of Administration
- 5.8 Market Breakup by End-User
- 5.9 Market Breakup by Region
- 5.10 Market Forecast
6 Market Breakup by Type of Bio-Implants
- 6.1 Cardiovascular Implants
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Dental Implants
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Spinal Bio-implants
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Orthopaedic Implants
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Ophthalmic Implants
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Material
- 7.1 Metallic
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Ceramic
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Polymer
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Biological
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Origin
- 8.1 Allograft
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Autograft
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Xenograft
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Synthetic
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Mode of Administration
- 9.1 Non Surgical
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Surgical
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by End-User
- 10.1 Ambulatory Surgical Centers
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Clinics
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Hospital
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Others
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
- 11.2 Europe
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
- 11.3 Asia Pacific
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
- 11.4 Middle East and Africa
- 11.4.1 Market Trends
- 11.4.2 Market Forecast
- 11.5 Latin America
- 11.5.1 Market Trends
- 11.5.2 Market Forecast
12 Global Bio-Implants Industry: SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Global Bio-Implants Industry: Value Chain Analysis
- 13.1 Overview
- 13.2 Research and Development
- 13.3 Raw Material Procurement
- 13.4 Manufacturing
- 13.5 Marketing
- 13.6 Distribution
- 13.7 End-Use
14 Global Bio-Implants Industry: Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Global Bio-Implants Industry: Price Analysis
- 15.1 Price Indicators
- 15.2 Price Structure
- 15.3 Margin Analysis
16 Bio-Implants Manufacturing Process
- 16.1 Product Overview
- 16.2 Raw Material Requirements
- 16.3 Manufacturing Process
- 16.4 Key Success and Risk Factors
17 Competitive Landscape
- 17.1 Market Structure
- 17.2 Key Players
- 17.3 Profiles of Key Players
- 17.3.1 Abbott Laboratories
- 17.3.2 Boston Scientific Corporation
- 17.3.3 Stryker Corporation
- 17.3.4 St. Jude Medical Inc
- 17.3.5 Medtronic Inc.
- 17.3.6 Smith and Nephew
- 17.3.7 Wright Medical Group
- 17.3.8 Zimmer Biomet
- 17.3.9 Dentsply Sirona
- 17.3.10 Invibio Limited
- 17.3.11 Straumann
- 17.3.12 Danaher Corporation
- 17.3.13 Cardinal Health
- 17.3.14 Johnson & Johnson
- 17.3.15 B. Braun Melsungen
- 17.3.16 LifeNet Health, Inc
- 17.3.17 Endo International plc